Newark AIDS Consortium Inc

Analysis

Newark AIDS Consortium Inc is a registered charity in United States, based in Newark, NJ. It received its IRS tax-exemption ruling in January 1990, 36 years ago. Its declared purposes cover diseases, disorders and medical disciplines, which this site groups under health and saving lives. The IRS classifies it as a hospital or medical research organisation under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Newark AIDS Consortium Inc reported income of $13.0m and spending of $12.8m, spending 98% of its income. Across the 5 years on record, from December 2019 to December 2023, income grew from $9.0m to $13.0m (+45%), an average of +9.8% a year. The sharpest change came in the year to December 2023, when income rose by 20%. Over the whole period it spent 99% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Newark AIDS Consortium Inc sits at the 86th percentile: it is larger than about 86% of them. Against every charity in United States with reported income it ranks in the 96th percentile, and in the 97th percentile within NJ. Charities of a similar size with the same main cause include Central Community Hospital ($13.0m), Better Health Together ($13.0m) and Southern Arizona AIDS Foundation ($13.0m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 17% and program service revenue 82% of the total. Compensation of current officers, directors and key employees was $559k (4.4% of expenses). Other salaries and wages came to $3.9m. At year end it held assets of $7.8m against liabilities of $3.8m, net assets of $4.0m. It reported 126 employees.